Unknown

Dataset Information

A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine.


ABSTRACT: In Africa, cervical cancer and placental malaria (PM) are a major public health concern. There is currently no available PM vaccine and the marketed Human Papillomavirus (HPV) vaccines are prohibitively expensive. The idea of a combinatorial HPV and PM vaccine is attractive because the target population for vaccination against both diseases, adolescent girls, would be overlapping in Sub-Saharan Africa. Here we demonstrate proof-of-concept for a combinatorial vaccine utilizing the AP205 capsid-based virus-like particle (VLP) designed to simultaneously display two clinically relevant antigens (the HPV RG1 epitope and the VAR2CSA PM antigen). Three distinct combinatorial VLPs were produced displaying one, two or five concatenated RG1 epitopes without obstructing the VLP's capacity to form. Co

SUBMITTER: Janitzek CM 

PROVIDER: S-EPMC6437161 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature